Evidence map›Paper›PMID 31695992›Full record

ReviewCureus2019

Biometals as Potential Predictors of the Neurodegenerative Decline in Alzheimer's Disease.

Liseth K Lavado, Michelle H Zhang, Karan Patel, Sohim Khan, Urvish K Patel

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. An ESIPT-Based Fluorescent Probe for Aqueous CuMolecules (Basel, Switzerland) · 2023
    Article
  4. A PET Fluorescent Probe for Dynamic PdMolecules (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Evaluation of Fluorescent CuMolecules (Basel, Switzerland) · 2021
    Article
  11. NEUROTOXICITY OF METAL MIXTURES.Advances in neurotoxicology · 2021
    Article
  12. Review
  13. Mechanisms Underlying Dysregulation of miR-132 in Alzheimer's Disease.Biomedical journal of scientific & technical research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Liseth K LavadoNursing, Rutgers School of Nursing, Newark, USA.
Michelle H ZhangPsychological & Brain Sciences and Biology, Johns Hopkins University, Baltimore, USA.
Karan PatelNeuroscience, Johns Hopkins University, Baltimore, USA.
Sohim KhanPublic Health, Icahn School of Medicine at Mount Sinai, New York, USA.
Urvish K PatelNeurology and Public Health, Icahn School of Medicine at Mount Sinai, New York, USA.
Johns Hopkins Medicine · USMount Sinai Health System · USIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's Disease (AD) is a debilitating neurodegenerative disease that is diagnosed by gradual memory loss and certain cognitive impairments involving attention, reasoning, and language. Most of the research on Alzheimer's disease focuses on the correlation of its neuropathological changes in the neurofibrillary tangles caused by hyper-phosphorylated tau protein and β-amyloid plaques with respect to cognitive impairment. Its pathology, however, remains incompletely understood. Currently, research has demonstrated that environmental factors such as biometals play a crucial role in exacerbating AD progression. The present review examines the role of metals in AD progression and how metal dyshomeostasis attributes to AD pathogenesis.  It was found that certain metals possess both beneficial and harmful properties in terms of AD progression. Depending upon the concentration of the metal of interest, copper, zinc, iron, and selenium have general beneficial properties. However, when present in excess, they can lead to oxidative stress and hyperphosphorylation of tau protein, amongst other harmful effects, while calcium and magnesium were seen to have beneficial effects by regulating biometal uptake.  In this review, we have provided evidential studies that focus on the involvement of certain metals in antioxidant pathways leading to the formation of reactive species indicative of neurodegeneration.

Indexed as

alzheimer’s diseaseamyloid-𝛽biometalscalciumcopperironmild cognitive impairmentneurodegenerative diseasezinc

Identifiers

PMID31695992
PMCPMC6820671
OpenAlexW2971438504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.